Epigenome editing of human hematopoietic stem cells enables sustained and reversible thrombosis prevention
This study demonstrates that transient delivery of DNA methylation-based epigenome editors to human hematopoietic stem cells enables stable, heritable, and reversible silencing of the platelet integrin ITGB3, resulting in sustained prevention of thrombosis through impaired platelet aggregation.